APA (7th ed.) Citation

X, S., A, A., N, P., M, F., A, I., F, M., . . . X, C. (2021). Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol. Contemporary clinical trials communications, 21, 100716. https://doi.org/10.1016/j.conctc.2021.100716

Chicago Style (17th ed.) Citation

X, Solanich, et al. "Pragmatic, Open-label, Single-center, Randomized, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Methylprednisolone Pulses and Tacrolimus in Patients with Severe Pneumonia Secondary to COVID-19: The TACROVID Trial Protocol." Contemporary Clinical Trials Communications 21 (2021): 100716. https://doi.org/10.1016/j.conctc.2021.100716.

MLA (9th ed.) Citation

X, Solanich, et al. "Pragmatic, Open-label, Single-center, Randomized, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Methylprednisolone Pulses and Tacrolimus in Patients with Severe Pneumonia Secondary to COVID-19: The TACROVID Trial Protocol." Contemporary Clinical Trials Communications, vol. 21, 2021, p. 100716, https://doi.org/10.1016/j.conctc.2021.100716.